Academic Journal
Q2Epileptic Disorders
About Epileptic Disorders
Epileptic Disorders is a scholarly journal published by John Wiley & Sons Inc.. SCImago 2025 lists it in Q2, with an SJR of 0.708 and H-index of 70.
Coverage: 1999-2026. Research categories: Medicine (miscellaneous) (Q2); Neurology (clinical) (Q2); Neurology (Q3).
Source-backed journal facts
Topics in published research
Epilepsy research and treatment; Pharmacological Effects and Toxicity Studies; Neuroscience and Neuropharmacology Research; EEG and Brain-Computer Interfaces; Neurological disorders and treatments; Neonatal and fetal brain pathology.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
2,430.00 USD; 2,100.00 EUR; 1,760.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
The effect of anti‐seizure medications on exposure to statins: A systematic review and meta‐analysis
Sharon Valiyev Huino, Hagar Cohen, Bruria Hirsh Raccah, Tomer Ben‐Shushan et al.
2026-10-03 · DOI: 10.1002/epd2.70416Intermittent photic stimulation in routine EEG : A practical guide
Natalia Olaru, Joana Jesus‐Ribeiro, David Asish Manchala, Irfan S. Sheikh et al.
2026-10-03 · DOI: 10.1002/epd2.70433Clinical spectrum of epilepsy in children treated at a tertiary pediatric neurology center—A hospital‐based cohort study
Dominika Sabova, Lucia Svecova, Marta Mikloskova, Miriam Kolnikova et al.
2026-10-01 · DOI: 10.1002/epd2.70428Persistence of electroclinical findings in an adult patient with SETD1B ‐related epilepsy
Rohan Shankar, Abdulrahman Bukhari, Irfan S. Sheikh
2026-09-30 · DOI: 10.1002/epd2.70414Anterior shoulder dislocation after tonic–clonic seizure
Jin’e Yuan, Yuting Xu, Sha Xue, Yanjuan Ye et al.
2026-09-30 · DOI: 10.1002/epd2.70380Integrating rapid response teams and structured care pathways improves outcomes in status epilepticus: A prospective cohort study
Xiao Fan, Yueming Dong, Jian Wu, Guanghui Zhang et al.
2026-09-30 · DOI: 10.1002/epd2.70397Meduna and the origins of the idea that seizures can be therapeutic
Eliza S. Schnitzer, Ronan Soltesz, Ivan Soltesz
2026-09-30 · DOI: 10.1002/epd2.70429Cardiovascular outcomes of enzyme‐inducing anti‐seizure medications: A real‐world Asian cohort study
Chun‐Yu Cheng, Ting‐Chung Wang, Chia‐Yu Hsu, Meng‐Hung Lin et al.
2026-09-30 · DOI: 10.1002/epd2.70430Use of an AI agent to improve epilepsy diagnosis
Juan G. Ochoa, Angie Zuniga, Luis Carlos Mayor
2026-09-28 · DOI: 10.1002/epd2.70401Epilepsy with eyelid myoclonia in a patient with CUX1 ‐related disorder
L. Maltoni, F. Palombo, G. Novelli, C. Giulianelli et al.
2026-09-26 · DOI: 10.1002/epd2.70405Beyond “status non‐epilepticus”: Toward a unified, accurate, and non‐stigmatizing terminology
Stephane Legriel
2026-09-26 · DOI: 10.1002/epd2.70424Status non‐epilepticus: Authors' response to León‐Ruiz et al.
Ronen Spierer, Moshe Herskovitz
2026-09-26 · DOI: 10.1002/epd2.70426Status non‐epilepticus: Authors' response to Legriel
Ronen Spierer, Moshe Herskovitz
2026-09-25 · DOI: 10.1002/epd2.70425Letter to the Editor: Status non‐epilepticus
Moisés León‐Ruiz, Julián Benito‐León, Carlos Castañeda‐Cabrero
2026-09-25 · DOI: 10.1002/epd2.70423Epilepsy in Alkuraya–Kučinskas syndrome: A longitudinal clinical characterization
Gaetano Maria Celardo, Matilde Neri, Gemma Marinella, Elena Andreucci et al.
2026-09-23 · DOI: 10.1002/epd2.70419Circulating blood biomarkers after traumatic brain injury: A subanalysis of the biperiden phase III randomized, double‐blind clinical trial ( NCT01048138 )
Michele Longoni Calió, Maira Licia Foresti, Luis Eduardo Santos, Amanda Cristina Mosini et al.
2026-09-22 · DOI: 10.1002/epd2.70372EEG reveals what the eyes can't see: A clinical vignette of epileptic visual loss
Zoi Kallia, Vasiliki Poulidou, Evripidis Pityrigkas, Panteleimon Ioannidis et al.
2026-09-22 · DOI: 10.1002/epd2.70412Diagnostic accuracy of the ADAS ‐Cog‐13 as a cognitive screening tool in older adults with focal epilepsy: A multicenter cross‐sectional study
Jessica Kania, Ifrah Zawar, Anny Reyes, Victoria Williams et al.
2026-09-21 · DOI: 10.1002/epd2.70415From triggers to ictal events: A video case series of reflex seizures
Laure Salmon, Nicolas Nguyen, Dang Khoa Nguyen, Olivier Aron et al.
2026-09-21 · DOI: 10.1002/epd2.70355Temporal lobe epilepsy with bilateral amygdala enlargement mimicking behavioral variant frontotemporal dementia
Kentaro Tokumoto, Takuji Nishida, Takashi Matsudaira, Etsuko Yamazaki et al.
2026-09-19 · DOI: 10.1002/epd2.70417Reviews
Community Reviews
Version History
October 2, 2026 at 9:05 pm
October 2, 2026